Age‐related accumulation of cholesterol accelerates CRC progression in humans by reducing SQLE, inhibiting GSK3β, and suppressing the p53 pathway, thereby providing valuable biomarkers for populations at high risk of CRC. Here, TP53 is linked to colorectal carcinoma.